IL12A , IL12B Goat Polyclonal Antibody
CNY 7,481.00
货期*
5周
规格
Product images
经常一起买 (1)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Applications | ELISA, WB |
Recommend Dilution | Sandwich ELISA: To detect hIL-12 by sandwich ELISA (using 100 ul/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with ProSci’s Polyclonal Anti-Human IL-12 as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hIL-12. Western Blot To detect hIL-12 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIL-12 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. |
Reactivity | Human |
Host | Goat |
Clonality | Polyclonal |
Immunogen | Produced from sera of goats pre-immunized with highly pure (>98%) recombinant hIL-12. Anti-Human IL-12 specific antibody was purified by affinity chromatography and then biotinylated. |
Concentration | lot specific |
Purification | IL-12 specific antibody was purified by affinity chromatography and then biotinylated |
Conjugation | Biotin |
Storage Condition | Store at -20°C as received. |
Background | IL-12 is a potent regulator of cell-mediated immune responses and it induces IFN-gamma production by NK and T cells. It is produced by activated monocytes/macrophage cells, B lymphocytes and connective tissue-type mast cells. Among its biological activities, IL-12 promotes the growth and activity of activated NK, CD4+ and CD8+ cells, and induces the development of IFN-gamma-producing Th1 cells. Recombinant Human IL-12 is a 75.0 kDa heterodimeric glycoprotein consisting of disulfide-linked 35 kDa (p35) and 40 kDa (p40) subunits (503 total amino acid residues). |
Reference Data |
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
其它IL12A , IL12B产品
Customer
Reviews
Loading...